Antineoplastic activity of lentiviral vectors expressing interferon-α in a preclinical model of primary effusion lymphoma

Blood

Volumn 113, Issue 19, 2009, Pages 4525-4533

  Calabrò, Maria Luisa ^a   Gasperini, Paola ^b   Di Gangi, Iole Maria ^a   Indraccolo, Stefano ^a   Barbierato, Massimo ^b   Amadori, Alberto ^a,b   Chieco Bianchi, Luigi ^b  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA1 INTERFERON; ALPHA2 INTERFERON; LENTIVIRUS VECTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; CYTOKINE; INTERFERON ALPHA-1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL INTERACTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MESOTHELIUM CELL; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; DRUG SCREENING; GENE VECTOR; GENETICS; KIDNEY; LENTIVIRINAE; MESODERM; METABOLISM; MOUSE MUTANT; PATHOLOGY; PERITONEUM;

ANIMALS; ANTINEOPLASTIC AGENTS; CELLS, CULTURED; CYTOKINES; DRUG EVALUATION, PRECLINICAL; FEMALE; GENETIC VECTORS; HUMANS; INTERFERON ALFA-2B; INTERFERON-ALPHA; KIDNEY; LENTIVIRUS; LYMPHOMA, PRIMARY EFFUSION; MESODERM; MICE; MICE, SCID; PERITONEUM;

EID: 66549108611     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-09-180307     Document Type: Article

References (35)

1. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus- like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186-1191.
2. Carbone A, Gloghini A. KSHV/HHV8-associated lymphomas. Br J Haematol. 2007;140:13-24.
3. Ascoli V, Calabrò ML, Giannakakis K, et al. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated polyclonal body cavity effusions that mimic primary effusion lymphomas. Int J Cancer. 2006;119:1746-1748. (Pubitemid 44258789)
4. Ensoli B, Stürzl M, Monini P. Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma. Semin Cancer Biol. 2000;10:367-381. (Pubitemid 30828787)
5. Pestka S. The interferons: 50 years after their discovery, there is much more to learn. J Biol Chem. 2007;282:20047-20051. (Pubitemid 47099975)
6. Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol. 2006;6:836-848.
7. Toomey NL, Deyev VV, Wood C, et al. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma. Oncogene. 2001;20:7029-7040. (Pubitemid 33052195)
8. Ghosh SK, Wood C, Boise LH, et al. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood. 2003;101:2321-2327. (Pubitemid 36302077)
9. Wu W, Rochford R, Toomey L, Harrington W Jr, Feuer G. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha. Leuk Res. 2005;29:545-555. (Pubitemid 40327243)
10. Abou-Merhi R, Khoriaty R, Arnoult D, et al. PS- 341 or a combination of arsenic trioxide and interferon- alpha inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells. Leukemia. 2007;21:1792-1801. (Pubitemid 47086768)
11. Carbone A, Cilia AM, Gloghini A, et al. Primary effusion lymphoma cell lines harbouring human herpesvirus type-8. Leuk Lymphoma. 2000;36:447-456. (Pubitemid 30103168)
12. Akedo H, Shinkai K, Mukai M, et al. Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers: a model for tumor invasion. Cancer Res. 1986;46:2416-2422. (Pubitemid 16120707)
13. Gasperini P, Barbierato M, Martinelli C, et al. Use of a BJAB-derived cell line for isolation of human herpesvirus 8. J Clin Microbiol. 2005;43:2866-2875. (Pubitemid 40827965)
14. Indraccolo S, Tisato V, Tosello V, et al. Interferon-alpha gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition. Hum Gene Ther. 2005;16:957-970. (Pubitemid 41153865)
15. Moserle L, Indraccolo S, Ghisi M, et al. The side population of ovarian cancer cells is a primary target of IFN-α antitumor effects. Cancer Res. 2008;68:5658-5668.
16. Dumont FJ, Coker LZ. Interferon-alpha/beta enhances the expression of Ly-6 antigens on T cells in vivo and in vitro. Eur J Immunol. 1986;16:735-740. (Pubitemid 16075771)
17. Dumont FJ. Recombinant human interferon-alpha A/D enhances the expression of Ly-6A/E, Ly-6C, and TAP antigens on murine T lymphocytes. J Interferon Res. 1988;8:347-356.
18. Boehrer S, Nowak D, Hoelzer D, Mitrou PS, Chow KU. The molecular biology of TRAIL-mediated signaling and its potential therapeutic exploitation in hematopoietic malignancies. Curr Med Chem. 2006;13:2091-2100. (Pubitemid 44132601)
19. Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med. 1999;5:157-163. (Pubitemid 29068521)
20. Said W, Chien K, Takeuchi S, et al. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood. 1996;87:4937-4943. (Pubitemid 26189834)
21. D'Agostino G, Aricò E, Santodonato L, et al. Type I consensus IFN (IFN-con1) gene transfer into KSHV/ HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in SCID mice. J Interferon Cytokine Res. 1999;19:1305-1316.
22. Herbeuval JP, Shearer GM. HIV-1 immunopathogenesis: how good interferon turns bad. Clin Immunol. 2007;123:121-128.
23. von Marschall Z, Scholz A, Cramer T, et al. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. J Natl Cancer Inst. 2003;95:437-448. (Pubitemid 36432418)
24. Aoki Y, Tosato G. Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas. Blood. 1999;94:4247-4254.
25. Foussat A, Wijdenes J, Bouchet L, et al. Human interleukin- 6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes. Eur Cytokine Netw. 1999;10:501-508.
26. Drexler HG, Meyer C, Gaidano G, Carbone A. Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines. Leukemia. 1999;13:634-640. (Pubitemid 29195295)
27. Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood. 1999;94: 2871-2879. (Pubitemid 29477316)
28. Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science. 2002;298:1432-1435. (Pubitemid 35346145)
29. Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem. 1997;272:19625-19631. (Pubitemid 27337768)
30. Aoki Y, Jaffe ES, Chang Y, et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood. 1999;93:4034-4043. (Pubitemid 29279245)
31. Mitani Y, Takaoka A, Kim SH, et al. Cross talk of the interferon-alpha/beta signalling complex with gp130 for effective interleukin-6 signalling. Genes Cells. 2001;6:631-640. (Pubitemid 32747202)
32. Staudt MR, Kanan Y, Jeong JH, Papin JF, Hines-Boykin R, Dittmer DP. The tumor microenvironment controls primary effusion lymphoma growth in vivo. Cancer Res. 2004;64:4790-4799. (Pubitemid 38924522)
33. Sanda C, Weitzel P, Tsukahara T, et al. Differential gene induction by type I and type II interferons and their combination. J Interferon Cytokine Res. 2006;26:462-472. (Pubitemid 44061086)
34. Indraccolo S, Pfeffer U, Minuzzo S, et al. Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol. 2007;178:1122-1135. (Pubitemid 46095185)
35. Rippo MR, Moretti S, Vescovi S, et al. FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells. Oncogene. 2004;23:7753-7760. (Pubitemid 39457025)